alendronate
alendronate: sourced relationships with 1 company · 2 clinical trials tracked · 1 FDA decision.
alendronate evidence translation
What we can confirm
1 FDA record · 2 tracked trials
What it means
What to watch
Prepared research question
How could alendronate → TEVA affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) Reported 2008-02-06 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (2)
Investigating the Efficacy of Romosozumab in Augmenting Bone Density and Muscle Mass to Enhance the Outcomes of Spine Surgery
Primary endpoint: Change in Hounsfield Units (HU) at L1 Vertebra
Efficacy of Alendronate Versus Placebo in the Treatment of HIV-1 Associated Osteoporosis, a Multicenter, Randomized, Controlled Trial. ANRS 120 Fosivir
Primary endpoint: Percentage of variation of lumbar BMD on DEXA scan at month 24 versus month 0 for patients included with lumbar osteoporosis (femoral for those included with only femoral osteoporosis)
Frequently asked questions
Which companies have sourced relationships with alendronate?
alendronate has dated SEC/FDA relationship records for Teva Pharmaceutical Industries Limited.
How many clinical trials involve alendronate?
BioSniper tracks 2 clinical trials involving alendronate.
What is alendronate's latest FDA decision?
The most recent tracked FDA decision for alendronate is Approval, dated February 6, 2008.